Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

(2013) Stuart Montgomery et al.   CURRENT MEDICAL RESEARCH AND OPINION

How well do randomized controlled trial data generalize to ‘real-world’ clinical practice settings? A comparison of two generalized anxiety disorder studies

(2013) Siegfried Kasper et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin

(2013) Charlotte Both et al.   Expert Review of Neurotherapeutics

Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder

(2013) Siegfried Kasper et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Cost Effectiveness of Pharmacological Treatments for Generalized Anxiety Disorder

(2013) Ifigeneia Mavranezouli et al.   PHARMACOECONOMICS

Pregabalin for the Treatment of Generalized Anxiety Disorder

(2012) Terri M Wensel et al.   ANNALS OF PHARMACOTHERAPY

Elucidating the Mechanism of Action of Pregabalin

(2012) Juan-Antonio Micó et al.   CNS DRUGS

Characterizing and understanding body weight patterns in patients treated with pregabalin

(2012) Javier Cabrera et al.   CURRENT MEDICAL RESEARCH AND OPINION

The adverse event profile of pregabalin across different disorders: a meta-analysis

(2012) Gaetano Zaccara et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

(2012) Karl Rickels et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Effects of pregabalin on sleep in generalized anxiety disorder

(2012) Edith Holsboer-Trachsler et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

(2012) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

(2012) Marina De Salas-Cansado et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Generalized anxiety disorder: diagnosis and treatment

(2012) E. A. Hoge et al.   BMJ-British Medical Journal

The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials

(2011) Gaetano Zaccara et al.   EPILEPSIA

Anxiolytic-Like Activity of Pregabalin in the Vogel Conflict Test in  2 -1 (R217A) and  2 -2 (R279A) Mouse Mutants

(2011) S. M. Lotarski et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial

(2011) Sallie J Hadley et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pregabalin: Dose-Response Relationship in Generalized Anxiety Disorder

(2011) M. Boschen   PHARMACOPSYCHIATRY

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

(2010) Howard N. Bockbrader et al.   CLINICAL PHARMACOKINETICS

A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system

(2010) Sofie Schwan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy and safety of treatments for refractory generalized anxiety disorder

(2010) Miny Samuel et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

(2010) Howard N. Bockbrader et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Current Considerations in the Treatment of Generalized Anxiety Disorder

(2009) Martin A. Katzman   CNS DRUGS

Long-term efficacy of pregabalin in generalized anxiety disorder

(2009) Douglas Feltner et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia

(2009) Stuart A. Montgomery et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis

(2009) Dan J. Stein et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

(2009) Siegfried Kasper et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder

(2009) R. Bruce Lydiard et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cognitive-Behavioral Therapy for Adult Anxiety Disorders

(2009) Stefan G. Hoffman et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

(2008) Stuart Montgomery et al.   BRITISH JOURNAL OF PSYCHIATRY

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update

(2008) Edoardo Spina et al.   CLINICAL THERAPEUTICS

Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies

(2008) Dan J. Stein et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

(2008) Borwin Bandelow et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Human and economic burden of generalized anxiety disorder

(2006) Deborah L. Hoffman et al.   DEPRESSION AND ANXIETY